Integra LifeSciences Holdings

Traded on the St. Petersburg Stock Exchange
Integra LifeSciences Holdings is one of the largest medical equipment manufacturers in the world. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care.
Integra LifeSciences Holdings stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Integra LifeSciences Holdings balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Integra LifeSciences Holdings cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

Integra LifeSciences Holdings multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

Integra LifeSciences Holdings profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Integra LifeSciences Holdings assets
Integra LifeSciences Holdings cash flows

Integra LifeSciences Holdings shares

TickerNameTypeNominal valueISINPrice
IART:USIntegra LifeSciences Holdings Corp.Common share-US4579852082$23.59
Integra LifeSciences Holdings news
27.04.2022
Integra LifeSciences Holdings' GAAP net income for 3 months of 2022 was $32.901 million, down 27.5% from $45.394 million in the previous year. Revenue increased 4.6% to $376.638 million from $360.071 million a year earlier.
Source: investor.integralife.com pictogram investor.integralife.com
Pictogram next
23.02.2022
Net income of Integra LifeSciences Holdings under GAAP for 2021 was $169.075 million, up 26.3% from $133.892 million in the previous year. Revenue increased 12.5% to $1.543 billion from $1.372 billion a year earlier.
Source: investor.integralife.com pictogram investor.integralife.com
Pictogram next
03.11.2021
Net income of Integra LifeSciences Holdings under GAAP for the nine months of 2021 amounted to $123.691 million, having tripled from $41.148 million in the previous year. Revenues increased 15.7% to $1.137 billion from $0.983 billion a year earlier.
Source: investor.integralife.com pictogram investor.integralife.com
Pictogram next
28.07.2021
Integra LifeSciences Holdings reported a GAAP net profit of $8.811 million for the six months of 2021, down 7 times from $62.492 million in the previous year. Revenue fell 17.5% to $612.989 million from $743.335 million a year earlier.
Source: investor.integralife.com pictogram investor.integralife.com
Pictogram next
All Integra LifeSciences Holdings news
General information
Company nameIntegra LifeSciences Holdings
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies
Business address311 ENTERPRISE DRIVE PLAINSBORO NJ 08536 6092750500
Mailing address311 ENTERPRISE DRIVE PLAINSBORO NJ 08536
Websitewww.integralife.com
Information disclosurewww.sec.gov